Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Coda Octopus Group, Inc. reported a 9.2% increase in total revenue to approximately $7.7 million in fiscal Q3 2026, driven primarily by a 68.3% rise in its Defense Engineering Services segment. Despite geopolitical instability curbing Marine Technology sales, strong growth in defense services and acoustics sensors supported overall improved financi…
Lyell Immunopharma, a late-stage clinical company developing next-generation CAR T-cell therapies for cancer, will participate in the Baird 2026 Global Healthcare Conference. Senior management will discuss the company's clinical progress and manufacturing capabilities via a webcast. The company emphasizes its proprietary manufacturing center's capa…
VisionWave Holdings, Inc. announced the filing of a U.S. non-provisional patent application describing ARGUS™, a proposed space-enabled, AI-driven counter-unmanned aircraft system (C-UAS) architecture. ARGUS integrates satellite surveillance, AI-based object recognition, resilient communications, and layered defensive technologies to detect and cou…
Tilray Brands announced the opening of a new Hop Valley Brewing Co. pub in downtown Eugene, Oregon. The new location, opening September 17, aims to serve award-winning craft beers, including the popular Dang Green IPA, and feature a sports-focused atmosphere for Oregon Ducks fans, enhancing community engagement and brand presence in the region.
MediWound Ltd. announced that the independent Data and Safety Monitoring Board (DSMB) recommends continuing the Phase III VALUE study of EscharEx for venous leg ulcers without any modifications, following a safety review. The company expects to complete enrollment by Q1 2027, reinforcing confidence in the drug's favorable safety profile and ongoing…
INmune Bio Inc. appointed R. Duane Clark II, a Sanofi rare-disease executive, and James Sapirstein, an experienced biopharma business development leader, to its Board of Directors. These appointments aim to bolster the company's commercialization planning for Ebstrocel™, a late-stage treatment targeting recessive dystrophic epidermolysis bullosa (R…
Macerich announced its participation in the BofA Securities 2026 Global Real Estate Conference, where its top executives will present and engage with investors, highlighting the company's position as a leading retail real estate investment trust with a substantial portfolio across key U.S. markets.
Corbus Pharmaceuticals announced positive topline data from its Phase 1b CANYON-1 study evaluating CRB-913 for obesity treatment. The oral CB1 inverse agonist showed statistically significant mean weight loss of 5% at 60 mg dosage after 12 weeks without weight loss plateau, and demonstrated a favorable safety and tolerability profile compared to or…
Senseonics Holdings announces a strategic partnership with Beta Bionics to integrate its Eversense 365 year-long continuous glucose monitor with Beta Bionics' iLet Bionic Pancreas automated insulin delivery system. The collaboration aims to commercialize a combined diabetes management solution by Q4 2026, offering enhanced ease and autonomy to pati…
Psyence Biomedical Ltd. (Nasdaq: PBM) announced the formation of Texas Ibogaine Research Corporation (TIRC) as a dedicated U.S.-based entity to coordinate the regulated development of pharmaceutical-grade ibogaine, including supply, regulatory engagement, and potential clinical trials. TIRC aims to hold U.S. rights to ibogaine developed by PsyLabs,…
Waldencast plc announced its intention to voluntarily delist its Class A Ordinary Shares and Warrants from Nasdaq by October 2026 and deregister under the Exchange Act. The company plans to rename itself Milk Makeup plc to align with its sole operating brand after selling Obagi Medical. Post-delisting, Waldencast intends to seek quotation on an ove…
Kimco Realty Corporation announced that its management will present at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026. The REIT is a leading owner and operator of grocery-anchored shopping centers and mixed-use properties in the U.S., focusing on high-quality assets in major metropolitan areas. The presentation will be…
Hain Celestial Group disclosed its fiscal year and Q4 2026 financial results, highlighting a 13% decline in annual net sales due to divestitures and organic sales declines. The company improved margins and free cash flow, reduced debt by over $140 million, and announced an agreement to sell its International business to focus on North American oper…
Brookfield Corporation (NYSE: BN) and Brookfield Asset Management (NYSE: BAM) will hold their Investor Day event in New York on September 17, 2026, offering live webcasts and presentations to provide updates on their business operations and strategic direction. The event aims to inform investors about the company's assets under management and long-…
Hain Celestial Group has agreed to sell its International business to private equity firm AURELIUS for an estimated $323 million in cash. The transaction aims to simplify the company's portfolio, focusing on its North American operations and reducing debt by using proceeds to pay down liabilities. The sale includes major international brands such a…
Telix Pharmaceuticals has received FDA approval for Pixclara®, a novel radioactive diagnostic PET imaging drug indicated to differentiate recurrent or progressive glioma from treatment-related changes in both adult and pediatric patients. This first FDA-approved FET-PET imaging agent for glioma offers physicians enhanced diagnostic precision and tr…
Parsons Corporation announced that nine of its digital defense solutions have been designated as 'Awardable' across two major Department of War digital marketplaces, Platform One and Tradewinds. This recognition facilitates faster government procurement and deployment of Parsons' innovative, mission-ready defense technologies, enhancing operational…
Westport Fuel Systems and Volvo Group's joint venture, Cespira, announced the advanced HPDI 3.0 fuel system that improves fuel economy, hardware durability, and system integration for heavy-duty engines using LNG and bioLNG. The technology supports broader engine configurations and future fuels like hydrogen, with production beginning in late 2026 …
TRX Gold Corporation announced its inclusion in the MVIS Global Junior Gold Miners Index (MVGDXJ) following the Q3 2026 index rebalance. This addition complements its recent inclusion in the S&P/TSX Global Mining Index and is expected to enhance the company's visibility among institutional investors and increase liquidity. TRX Gold operates the Buc…
TRX Gold Corporation announced record quarterly gold production of 8,173 ounces in Q4 2026, a 28% increase year-over-year, and full year production of 29,650 ounces, surpassing previous year's output by 57% and reaching the top end of their 2026 guidance. The company benefited from a strong average gold price of approximately $4,233 per ounce in Q4…
Equifax Canada's Q2 2026 report indicates Canadian businesses are increasing their debt loads by 7.3% year-over-year while facing heightened payment delinquencies, particularly with banks and lenders. Trade tariffs have added uncertainty, especially impacting higher-risk and younger businesses, with notable increases in restructuring proposals. Alt…
Zoom unveils the "Zoom Got It Done" advertising campaign starring Kate McKinnon to emphasize its AI-enhanced platform that extends beyond video meetings to an ecosystem of productivity solutions, aiming to advance its 'conversation to completion' strategy.
The Elmet Group announced it will allocate $450 million of investment from the U.S. Department of War to enhance and secure the U.S. tungsten supply chain through expanding domestic manufacturing, restarting mining operations, and establishing partnerships with allied suppliers. This strategic move includes modernization of existing facilities, cre…
The Elmet Group Co., a NASDAQ-listed U.S. provider of critical materials including tungsten, announced a $450 million committed investment from the U.S. Department of War to enhance domestic tungsten production and processing capabilities. The investment aims to reduce foreign dependence, expand manufacturing facilities in Maine, Michigan, and Ohio…
BioNTech, in collaboration with OncoC4, announced updated Phase 3 trial data showing that their investigational immunotherapy gotistobart significantly improves median overall survival to 18.5 months versus 10.0 months with standard chemotherapy in patients with previously treated squamous non-small cell lung cancer. The therapy's novel mechanism s…
